Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease diabetes mellitus, insulin-dependent
Symptom |nephropathy
Sentences 76
PubMedID- 21355059 Is treatment of nephropathy in type 1 diabetes efficacious but ineffective.
PubMedID- 25767718 Objective: this study explored the annual occurrence/incidence of bacterial infections, and their association with chronic hyperglycemia and diabetic nephropathy, in patients with type 1 diabetes.
PubMedID- 23877984 Research design and methods: using the nationwide finnish diabetic nephropathy (finndiane) study cohort of 4,083 patients with type 1 diabetes (mean age of 37.4 +/- 11.8 years at enrollment), we analyzed the incidence of first-ever sah events.
PubMedID- 20718958 However, in the presence of target organ lesions or other cardiovascular risk factors - like type 1 diabetes (t1d) with nephropathy or even t2d - the goal is to obtain levels below the 90th percentile.
PubMedID- 24026551 Reduced insulin sensitivity has also been shown to predict diabetic retinopathy, neuropathy, and nephropathy in subjects with type 1 diabetes (13).
PubMedID- 24658196 Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a spanish population.
PubMedID- 20332124 Conclusions: these findings suggest a role of inflammation and endothelial dysfunction as markers and contributors of the development of diabetic nephropathy in persons with type 1 diabetes mellitus.
PubMedID- 24527422 Continuous microalbuminuria (30-299 mg/day) appears in the early stages of diabetic nephropathy with type 1 diabetes, and it is an indicator of nephropathy onset and the development of cardiovascular disease 5.
PubMedID- 22332940 Data from the diabetes control and complication trial have been reanalysed to ascertain whether the frequency of severe hypoglycaemia exerted an influence on the development and progression of retinopathy or nephropathy in people with type 1 diabetes.
PubMedID- 21810600 It is likely that leptin is beneficial for nephropathy in patients with insulin-dependent diabetes.
PubMedID- 20687937 Genome-wide dna methylation analysis for diabetic nephropathy in type 1 diabetes mellitus.
PubMedID- 22819809 Introduction: persistent microalbuminuria is the accepted marker for early detection of a high risk of developing diabetic nephropathy in patients diagnosed with type i diabetes mellitus.
PubMedID- 23681557 We hypothesised that variations in the cd2ap gene may contribute to susceptibility to glomerular injury in diabetes and investigated if single-nucleotide polymorphisms (snps) in cd2ap are associated with diabetic nephropathy in patients with type 1 diabetes.
PubMedID- 22696035 Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s.
PubMedID- 20573241 Background: microvascular complications, including retinopathy and nephropathy are seen with type 1 diabetes.
PubMedID- 25740786 An elevated level of growth hormone (gh) is implicated as a causative factor in the development of nephropathy in patients with type 1 diabetes mellitus.
PubMedID- 22608880 Associations of sod1 gene variants with diabetic nephropathy were reported in patients with type 1 diabetes.
PubMedID- 19395281 Endoglin expression levels and diabetic nephropathy risk in patients with type 1 diabetes.
PubMedID- 25622104 The possible benefit of lasp1 as a biomarker is not restricted to cancer, as lasp1 is one out of 12 differentially expressed proteins that show decreased expression in cultured skin fibroblasts of insulin-dependent type 1 diabetes mellitus patients with diabetic nephropathy versus diabetics without nephropathy or healthy subjects.
PubMedID- 26339138 A very recent publication reports a close association between ficolin and diabetic nephropathy in patients with type 1 diabetes .
PubMedID- 21533091 In contrast to previous studies in which good glucose control prevented, but did not reverse, nephropathy in a model of type 1 diabetes 2, in the present studies the ketogenic diet reversed nephropathy, as reflected by albumin/creatinine ratios, after it had developed in models of both type 1 and type 2 diabetes.
PubMedID- 22518298 Clinically, inflammatory processes in the kidney also contribute to the progression of nephropathy in patients with type 1 diabetes and in diabetic animal models .
PubMedID- 20456170 Evidence suggests that the increase in cvd risk in type 1 diabetes is largely associated with nephropathy (60–64).
PubMedID- 21270197 High serum lps activity also associates with the development of diabetic nephropathy in patients with type 1 diabetes (10).
PubMedID- 19918004 In particular, several lines of evidence have highlighted the fact that predisposition to hypertension might be a risk factor for the development and progression of diabetic nephropathy in individuals with type 1 diabetes (4–8), and, therefore, the inheritance of blood pressure–related genes might also contribute to abnormal albumin excretion and renal damage.
PubMedID- 24983394 Early diabetic nephropathy in type 1 diabetes: new insights.

Page: 1 2